Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.

The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

When doctors are accused of mishandling the heart health of a young athlete, it occasionally ends up being settled in a courtroom. 

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients. 

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms. 

It may not always be necessary to subject heart transplant patients to one biopsy after another. 

Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.

A prominent doctor and multiple family members are dead after an Israeli airstrike. "Thousands of heart patients will suffer as a result of his killing," one colleague said.